XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.300
-0.090 (-3.77%)
Apr 28, 2026, 4:00 PM EDT - Market closed
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $5.72 million as of April 28, 2026. Its market cap has decreased by -64.70% in one year.
Market Cap
5.72M
Enterprise Value
5.52M
1-Year Change
-64.70%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $5.72M, a decrease of -96.82%. That is a compound annual growth rate of -15.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 6.24M |
| BioRestorative Therapies | 5.93M |
| CollPlant Biotechnologies | 5.91M |
| Moolec Science | 5.87M |
| Ernexa Therapeutics | 5.83M |
| Aptevo Therapeutics | 5.81M |
| Mustang Bio | 5.76M |
| PMGC Holdings | 5.59M |